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Public Policy on the Introduction of
Genetically Engineered Microorganisms
ANNE K. VIDAVER
Department of Plant Pathology, University of Nebraska, Lincoln, NE 68583
This presenration raises questions of research needs and issues. Underlying assumptions are that only beneficial or useful microorganisms
will be "released"; that extensive laboratory and conrained experiments will have been done prior to inrroduction and live microorganisms
can be confined within the areas of inrroduction. Evidence to support these assertions will be presenred. Critical needs for progress in this
area include: 1) Recognition that the nature of the product inrroduced inro the environmenr is of primary significance, not how the
organism was genetically altered or modified. 2) Recognition that microorganisms are introduced inro the environmenr as part of our
daily lives. 3) Classification of microorganisms into categories, include a GRACE (Generally Regarded as Compatible with the
Environmenr) list. For example, most microorganisms used by humans in food and agriculture would be on such a list. 4) Categorization
of"new" traits transferred to microorganisms: all are not equal. 5) Revision of the Planr Pest Act. Inrerpretation by the USDA is now so
broad that almost any microorganisms may be a "planr pest". 6) Developmenr of the means to enable conrinuarion of basic research in
small-scale traditional tests with GEMs. 7) Recognition of the adequacy of the methods used for mitigation and deconramination of
microorganisms. 8) Development and use of selective, narrow spectrum chemicals and biologicals. 9) Critical evaluation of appropriate
regulations and attendanr costs for research on GEMs in the environment. These issues need recognition and wide-spread support among
scienrists, policy-makers and the public if the potenrial uses for microorganisms in the environmenr are to be realized.
INDEX DESCRIPTORS: bioethics, biotechnology, genetic engineering, microorganisms, public policy

As the last speaker, I am going to talk about some more general
areas of biotechnology, genetically engineered microorganisms and
genetically modified organisms. I was specifically asked to discuss
some critical questions regarding the introduction of genetically
altered microorganisms into the environment, and, to me, genetically
engineered microorganisms are a subset of that category.
I want to give you the take-home message first, because that will
give you something to ponder as I make my presentation. My takehome message is essentially that with respect to the introduction of
genetically engineered microorganisms into the environment, I think
we are at a critical phase in this country. I think we either have to have
reasonable guidelines and regulations within the next 12 to 18
months, or, in my opinion, we jeopardize the whole area of academic
research and ultimately agricultural competitiveness. My reason for
emphasizing academic research is I think that most people in this
audience and others as well would agree that academic research
provides the foundation for commercial and public development and
use of science, including these types of microorganisms.
Let me begin by defining what I'm talking about. First, when we
are talking about genetics, which we have been doing, we are talking
about the hereditary properties of microorganisms (Fig. 1). By
convention we talk about any microorganism as well as other types of
organisms (plants or animals) that are in the environment as so-called
"wild-type", but I wish to emphasize for those who don't think about
it, that these populations are highly variable to begin with. Then we
have a variety of changes that occur, and the changes that we are most
familiar with in history are those that are labeled spontaneous. That
simply means we don't know enough to be able to explain what has
happened, but we obviously have those changes.
In commerce and industry, we have used physical and chemical
agents to provide those changes and ultimately end up with genetically altered or modified microorganisms. Where we have a new
technology is in being able to use specific enzymes in recombinant
DNA technology to provide genetically engineered microorganisms
(GEMs), but what we end up with is, again, a genetically altered or
modified microorganism. It is simply different in kind.
Now, many people think that genetically altered products are
something alien, but I would like to remind people that we are
familiar with and comfortable with genetically altered products in
public use. Very quickly, because time is short, I will indicate that all

of our domesticated animals are essentially genetically altered products. We have our beef coming from very genetically altered cattle.
We are not eating wild cattle, at least as far as I know. Similarly, with
domesticated plants, Pioneer would not be in business if we were not
dealing with domesticated plants.
We are familiar with microorganisms on a daily basis. Some of you
are going to have yogurt for lunch, for example. Those are live
microorganisms in there, and if you eat different brands of yogurt, you
will realize that each one has a slightly different taste. That is because
you have a different organism in each one of those brands. In
agriculture, many of you are familiar with the legume inoculants that
provide nitrogen fixation for those crops, and so on.
We have a history of using genetically altered products in our
collective experience, and we also have a history of using genetically
altered microorganisms in research. We are asking all kinds of
questions about how these microorganisms behave and function. In
legume inoculants, for example, we are interested in competition in
nitrogen fixation, one aspect of those microorganisms.
Wild-type (populations variable)
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Fig. 1. Generic (hereditary) properties of microorganisms.
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Similarly, with silage inoculants, there is interest in how to make
them function better in terms of providing nutrition for the animals
that eat them, how to preserve the materials longer, and so on. And
then, in terms of bacteria that could promote intensive growth of
plants, or at least healthier growth of plants, many people have found
such types of microorganisms. There also are organisms that can be
used in animals and organisms that can be used as biological control
agents. There are many different kinds of organisms that can be used
in this fashion, some of which are useful in weed control (e.g.,
mycoherbicides) and the microbial pesticides which you have heard
about. People modify them in standard ways, mostly to put in what
we call markers to identify them, or to put in genetic material or
modify them so that we can determine by reference to the original
organism just what it is that the modified organism actually does.
When we consider genetically engineered microorganisms, we
have a lot of laboratory experience, but when we come to the question
of what has actually gone into the environment, at the present time we
really have only three examples, one of which is yet to go in this
spring. Rhizobium meliloti is a legume inoculant of alfalfa which
presumably will be more efficient in nitrogen fixation. The only way
to find that out is to actually do the experiment. Again, we are talking
about very minor modification in a wild-type organism. The Pseudr!monas fluorescem is simply a test organism that can live on roots, and
that is the one that is publicized through the experiments being done
at Clemson University, sponsored by Monsanto. Then you have Steve
Lindow's experiment being done with Pseudomonas syringae.
What we have now is, I think, a situation where only these very
minor tests are going into the environment, but they get a lot of
publicity. I think it is unfortunate in the extreme that except for
Steve's experiment, from the academic community, as far as I can
determine, we will not have a single experiment that goes out into the
environment this year. Now, as he has indicated, it is extremely
difficult, tedious, and time-consuming, and he didn't even mention
money - something that I will discuss in a moment.
I think we have to distinguish in these categories fear vs. risk, and I
think that is something that we all tend to forget. For example, we all
fear food poisoning, but when you go to the grocery store and buy
some yogurt, you know that there is a very low probability, practically
zero, that it is going to make you sick. We have no fear of getting up
in the morning, at least I don't think we do, although we know by all
the figures that our households are very risky. There are more dangers
in our homes than virtually anywhere else, at least if we believe some
of these statistics. So we need to distinguish fear vs. risk. An example
of what fear has generated in terms of genetically engineered microorganisms is illustrated in several cartoons. They make for good show,
but indicate the anxiety of some people with respect to microorganisms, and of course, I'm taking the prejudiced view that this is fear
and not warranted by risk. It is fear, in my view, and hypothetical risk
that is driving the regulatory policies, not only in this country but
throughout the world. This is illustrated by a very recent issue of
Biotechnology which indicates the world regulatory patchwork with
respect to the regulation of biotechnology and, under this, the subset
of microorganisms. This has generated not only a large bureaucracy
which is beginning to emerge, but the bureaucracy has, in my view,
conflicting and overlapping jurisdictions. As I have indicated, I think
these are having very deleterious effects, not always based on science.
One of the questions that was raised for us to consider was
dissemination of microorganisms. Plant pathologists have been working with actually harmful organisms scientifically for at least 150
years. We know a great deal about quite a few microorganisms, even
bad ones. I want to illustrate with this slide that you can see the
location of microorganisms right down to the row. The plants on the
right which had a fungus infection are stunted and not very healthy. In
the middle, the row of plants which were treated with a biological
control agent (a soil microorganism) essentially resemble the un-
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treated controls that are on the lefr. In many cases we can predict very
well the dissemination of microorganisms very, very precisely, and
that applies above ground as well as below. We are down to one row of
bean plants that have been inoculated by a plant breeder vs an adjacent
row of bean plants that have not been treated. This is done routinely.
The inoculated plants are sick after a while, which is what we
expected, and the untreated, control plants do not get sick even
though they may be there the whole season. Sometimes there is some
cross-over, but basically those plants are contained.
We have a long history, going back over 150 years, and I estimate
approximately 100,000 tests in the environment, in which these tests
have been done with harmful, known organisms. What is dramatic
and is not recognized by the public, much less the press, is that we
have not had any documented evidence that such tests have created an
epidemic. They have not created any harm, therefore they don't make
the news. But I think we have to take those kinds of situations into
account as we are talking about realistic policy with respect to
genetically engineered microorganisms.
So we have, in my view, a high degree of safety built into these
kinds of experiments in the environment. To relate it to something
that perhaps many of you are familiar with, it isn't just scientists who
are involved with the dissemination of microorganisms. I presume
that most of you in the audience have seen some of the tulips around.
None of those tulips have come from Iowa. All of those tulips, to my
knowledge, have come from the Netherlands and each one of those,
when it is planted, has at least a million associated organisms about
which we know nothing. Now, if you take 100 of those tulips and
make a nice little bed, you've got approximately 100 million
microorganisms in your yard, and we collectively have the experience
that nothing happens. The world is still here after we have planted all
those tulips all over the world. That's from the public.
From the agricultural sector, we also have the experience collectively of many farmers throughout the world using legume inoculants,
particularly Rhizobium and now Bradyrhizobium, to inoculate such
crops as alfalfa and soybeans. Again, those organisms have gone all
over the world. There is, to my knowledge, no documented case that
in spreading all those bacteria all over the world for at least a quartercentury there has been any harm to the crops. On the contrary, they are
considered to be beneficial and sometimes essential to get that crop
established.
I want to illustrate another facet of microorganisms that I am
interested in besides the pathogens; these are organisms that live
inside plants. Simply, I am calling them endophytic bacteria. We take
them out of stalks of corn and sorghum. This material is perfectly
healthy in appearance. You don't see any visible microorganisms, and
yet by techniques that are customary in microbiology, we can find a
whole array of microorganisms. I'm particularly interested in bacteria.
Plants that are perfectly healthy, even inside, harbor many kinds of
microorganisms. What I am particularly interested and intrigued by
is that the populations roughly divide into two: the population that,
when you inoculate plants, will die after some period of time (those
aren't particularly interesting) and the ones that, after you inoculate,
will either maintain themselves or grow. Then my question is how to
capitalize on such organisms in ways that you have heard already from
earlier speakers, and that includes such properties as whether or not
they can produce something beneficial (e.g., antimicrobial against a
deleterious organism), whether or not they themselves could be
insecticidal or you could put the Bt toxin gene into one of these
bacteria, whether or not they would produce plant growth regulators,
whether indeed they could also provide herbicide resistance to the
plants or such genetic material could be inserted into one or more of
them, or whether or not they could improve the nutritional qualities
of plants, such as lysine in corn. These are all speculative, and the
prospects of doing any one of them is very small, but not zero. This is
something that we would be aiming towards, but my guess is that it
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would take us at least a decade or more, if in fact we even succeed to a
limited degree.
That brings me to considering some of the strategies and attributes
of chemicals and microorganisms that are used in plant health and
protection (Table 1). I think most of us would agree that we would like
to diminish the use of chemicals as far as possible, but I think that
means you can't have it both ways. That is, if we are talking about
plant health and protection, if we don't have chemicals, what else are
we going to do? One answer, and by no means a panacea, is to use
microorganisms. As indicated earlier, one of the questions and
concerns is whether or not these microorganisms multiply. Chemicals, of course, don't multiply; microorganisms can, but in most cases
they are very limited. As you have seen, they die out for the most part.
There are some exceptions, but the idea of their taking over the world,
which is in some scenarios, is in my view not scientifically tenable.
Shelf life is a commercial concern, and that's actually where microorganisms are at a disadvantage because their shelf life is virtually
minuscule compared to the majority of chemicals.
The cost of production for chemicals, all the way from the research
co the manufacture to the consumer price, is usually quite high, and
the prediction is that these costs are going to go higher because of the
many variables that are involved. We can talk about those if time
permits. To me, the irony with biologicals is that in many cases the
cost, all the way from the research to the consumer, could be very low,
but as you have seen, the costs are likely to be very high, and perhaps
in many cases, higher than many chemicals, because of what I consider
undue stringency at the present time in requirements for getting these
products into the marketplace.
In terms of persistence, chemicals, of course, are highly variable,
and as we have indicated, microorganisms rarely persist. In pollution
potential, again, chemicals are variable. The pollution potential of
microorganisms is very low, and I don't know of any case where this
has been an issue. In terms of commerce, what companies wish to do
in regard to specificity, of course, is to have something that will take
care of all your problems - one pass-through and everything you
don't like will be taken care of. That, of course, is an ideal, but then
what you end up with is the concern with destroying or harming nontarget organisms. Whereas, with biologicals, you have almost the
reverse situation where you very commonly have the specificity
actually being a deterrent to the commercialization. It is a very
difficult issue.
Safety with chemicals is extremely variable, as you know. I was
trying to find a case where any of the microorganisms we have used in
the environment, either for biological control or plant pathogens, had
any documented adverse effect, and I couldn't find any. That doesn't
mean it can't exist, but it means we have a very large database to show
that we do not have a problem with the organisms that we are
presently using, and that is basically ignored by the public press.
That brings me to the last point. In assessing the critical needs for
planned introduction of genetically engineered microorganisms

Table 1. Strategies and Attributes of Chemicals and
Microorganisms Used in Plant Health and Protection
Strategy/Attribute
Chemicals
Microorganisms
Replication
No
Yes (limited)
Shelf-life
Long
Short
Cost
High
Low to Very High
Persistence
Variable
Rare
Pollution potential
Variable
Low
Specificity
Rare
Common
Safety
Variable
Absolute (?);
No known adverse
effects

Table 2. Critical Needs for Planned Introductions of GEMS
Situation: Agrichemicals being deregistered; few to no alternatives;
pesticide concerns and costs: new product potential.
GEMs: one alternative.
1. Public differentiation between fears and risks.

2.
3.
4.
5.

Public media role: history and use of microorganisms.
Differentiation between research and commercial development.
Reasonable guidelines, regulations based on science.
GRACE classification: (Generally Regarded as Compatible
with the Environment).
6. Categorization of 'new' traits transferred to microorganisms.
7. Revision of Plant Pest Act.

(Table 2), I put down a statement of our present situation which is not
all-encompassing but just some items so that I wouldn't forget to
comment on them. One of these is that the chemicals that we are
using in agriculture are being de-registered. I'm not quarreling with
that, but it means that we have few to no alternatives to several
agricultural chemicals and that is going to come home to roost in
approximately 3 to 5 years in my estimation. There are legitimate
concerns about pesticides and their costs, and we can certainly discuss
those.
The new product potential for chemicals is essentially limited to
herbicides and a few pesticides, but there is a new product potential
for genetically engineered microorganisms if, in fact, we want co use
them. Genetically engineered microorganisms, in my view, are
simply one alternative; they are not a panacea. As I have indicated, we
have to differentiate between fears and risks, and this is not always
done. We need to have public media play a more active role in
demonstrating that microorganisms have been used in the environment for various purposes, both by the public and by scientists, for a
long period of time, and that the world is still here and is likely to
remain so.
We need, in my view, a differentiation between research and
commercial development. For example, Dr. Dean talked about the
requirements for registration of a microbial pesticide. This is fine
when you are talking about a product, but if you are just starting out
and are trying to determine whether or not that microorganism
actually does something, you have to be able to do the preliminary
work to determine whether or not it is even worth bothering to go
ahead, and that distinction is blurred in my mind at the present time.
We need, in my view, reasonable guidelines and regulations that are
based on science and not on fear. In my judgment, it is scientifically
bordering on fraud to have had the investigators monitoring Steve
Lindow's field test put on special suits. It implies that those organisms
are dangerous to work with. We have worked with those organisms
for nearly 100 years in various environments. They pose no danger,
and it is unfortunate that that perception is put forth.
We have to have recognition that not all microorganisms are the
same, and I am suggesting that we have to have something like a
GRACE (Generally Regarded as Compatible with the Environment)
classification. There clearly are microorganisms that are generally
regarded as compatible with the environment, and the chief illustration is Rhizobium. We have been working with that organism for over
a hundred years with no problem. We need to recognize that that is
not the same thing as something that is going to kill a com plant.
Likewise we need categorization of new traits that are transferred to
microorganisms. They are not all the same. Something that is going
to provide a nutritional base to a plant that it did not have before is not
going to be the same thing as a vertebrate toxin that has a potential to
harm a human being.

PUBLIC POLICY

Then finally, one of my pet concerns is revision of the Plant Pest
Act, with which most of you probably are not familiar. The Plant Pest
Act is now being interpreted by the USDA so broadly that virtually
any microorganism that affects a plant or even a plant derivative and
its products can be considered to be a plant pest. One of the primary
illustrations that I think demonstrates there is a problem here is
Rhizobium which now falls in that category. Farmers probably do not
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know that the USDA now considers Rhizobium a plant pest and yet
recommends it as a legume inoculant - a logical inconsistency to me.
I think that I have raised a number of issues here. It comes down to
this: if we are going to be competitive and if we are going to realize the
benefits, particularly of genetically engineered microorganisms, we
n~ public support, and we need a reasonable public policy. In my
view, we have a long road ahead.

Questions and Discussion
ARTHUR WEISSINGER, Moderator

(Weissinger) Thank you, Dr. Vidaver. That gave us a lot to think
about. Now I'd like to move on to a couple of people who have agreed
to serve as our representatives to ask questions of these biologists. The
first will be Dr. Donald Huffman who is Chair of the Department of
Biology at Central College in Pella, where there probably are many
hundreds of millions of microorganisms residing on tulips. Dr.
Huffman comes from a biological background, trained as a plant
pathologist, and is, I think, an excellent person to ask questions from
a biological perspective, but as a person who is not directly involved in
this kind of work.
(Huffman) I don't think that most of you expect nor would you
appreciate a lot of comments of my own. Instead, I would like to move
directly to some questions that I would like to have addressed. I do
thank our speakers for a very fine coverage of the topic. There is one
question I would like to address to all three individuals.
Do we have good information on the extent to which altered genes
can be transferred to other organisms besides the target organism of
Bacillus or other genera? In other words, what is the likelihood of
transfer of these genes to other natural ecosystem bacteria?
(Dean) In many cases we know that mechanisms exist, but we have
no examples in the case of Bacillus thuringiensis, which is the major
experiment I mentioned that has been conducted, of genes being
transferred out of or into this organism. I might say that the genes that
encode the toxins for insect toxicity are borne upon plasmids, which
would make them excellent candidates for transfer into other organisms and some other bacilli which exist in nature that couldn't
possibly transfer their genes, if they would be harmful, into this
massive inoculum of Bacillus thuringiensis. I think that since we have
no examples of this, we could ask, "Have we done all the experiments
we need to do to find cases?" I think certainly not. The field of
microbial ecology has been compared to microbiologists attempting
to study their subject without microscopes. That should have caused a
roar of laughter, but it didn't. At any rate, this area of microbiology
has been, in fact, the least funded and most ignored, and now at least
it's coming into its own light as many other subjects do in the
evolution of time.
Nevertheless, scientifically we know that if genes are to be
transferred and persist, there must be some selective advantage for the
recipient organism to receive these genes. It is simply not a scientific
response to say yes, the mechanism is known, and therefore make up
your own answer. We have to perceive that there would be some
selective advantage in the case of the microorganism to have the genes
to open up a new niche for itself, and if this is to be the case, we have to
imagine what those selective advantages might be.
(Huffman) I could speculate on what it might be if you had, let's say,
endophytic organisms such as were mentioned here, and you could
alter those endophytic organisms, that could presumably be an
advantage to the organism harboring them.

(Dean)

Which way would you alter them?

(Huffman) If you were able to take, let's say, insect resistance
conferred by Bacillus thuringiensis and to incorporate that into one of
these endophytic organisms, surely that would be of some advantage
to the host plant harboring the endophytic organisms.
(Dean) Well, there would have to be an advantage to the endophyte: It would have to create a new niche for insect pathogenesis, and
that involves a number of steps. It involves the fact that the
~icroor~anis~ would. be able to maintain itself in a pathogenic
mteracnon with that msect and detailed, subtle, and multifaceted
interactions. It could not be assumed that now I have a gene and can
be king of the world. The development of a pathogenic situation is
very fine tuned, and I think most of us are working in this area of
microbial genetics have a great sense of deja vu. We are asking
ourselves, "Didn't we discuss these things ten years ago when
:ec~mbinant DNA. first come. out?" When epidemiologists first
md1Cated that E. colt, the gut m1Croorganism of humans, happens to
be t~e major experimental tool we are using in the laboratory, the
reaction was, "Wow, you stick things in there and they happen to get
out, and there are going to be some pathogens to humans." The
epidemiologists have spoken on this more than ten years ago and have
said that it was a ludicrous assumption. What is necessary is for the
public to be cognizant of the terms of which they speak when they
make that decision.
(Vidaver) I will comment just briefly on that endophytic question.
It turns out there is a company using a similar approach that wants to
put out an endophytic bacterium similar to mine with precisely that
toxin in it. The proposal is being evaluated by the EPA. Experimentally the difficulty with that organism is to have that toxin expressed
long enough for it to be effective. The probability of transfer is
extremely low, even in experimental situations. People who have not
w~r~ed with microbes might need to know that you need literally
millions and sometimes billions of cells in order to find a single
transfer. You have to recognize also that there are probably at least a
million microorganisms catalogued throughout the world, and we
think that we don't even know about half of them yet. They are all
distinct, and they remain distinct. Obviously if we had easy genetic
transfer from one microorganism to another, we would have only one
or two of them. So, it isn't easy, but that does not mean it can't work.
(Huffman) To me, this represents a very good situation in which one
cannot extrapolate, let's say, from antibiotic resistance which does
appear to be of some concern, to a situation like this.
(Vidaver) That is correct, and the common thing about that is, that
typically that works under selective conditions.
(Lindow) I was going to add that we can basically assume that some
transfer would almost inevitably occur in almost all organisms. This
can't be demonstrated in natural environments. Some transfer does

